Cox, Johnson, and Alexander (2012) report cochlear dead regions (DRs) occur when inner hair cells at a given frequency are lost or malfunctioning. Previous publications have suggested hearing-aid high-frequency gain should be attenuated in the presence of high frequency DRs.
Precondition for a VdS approval procedure, among others, is proof of a certified quality management system in accordance with DIN EN ISO 9001 for the manufacturing facility of the product.
brentuximab vedotin was granted an accelerated approval in august 2011 as a treatment for patients with hodgkin lymphoma after failure of asct or after failure of at least two prior chemotherapy regimens in patients who were not candidates for asct